Want to join the conversation?
Biopharmaceutical company $AMGN said European Commission (EC) granted marketing authorization for its Kyprolis drug in combination with lenalidomide and dexamethasone for treating adults with multiple myeloma (incurable blood cancer) who have received at least one prior therapy. EC approved Kyprolis based on data from pivotal Phase 3 aspire trial.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!